logo

Stock Screener

Forex Screener

Crypto Screener

ACA

Arcosa, Inc. (ACA)

$

112.22

+1.00 (0.89%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

6.4335

Market cap

Market cap

5.5 Billion

Price to sales ratio

Price to sales ratio

1.9428

Debt to equity

Debt to equity

0.6124

Current ratio

Current ratio

2.0221

Income quality

Income quality

3.1581

Average inventory

Average inventory

210.3 Million

ROE

ROE

0.0596



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Arcosa, Inc., along with its subsidiaries, specializes in providing infrastructure-related products and solutions targeting construction, energy, and transportation markets across North America. The company operates through three main segments: Construction Products, Engineered Structures, and Transportation Products. Within the Construction Products segment, Arcosa offers a range of natural and recycled aggregates, specialty materials, as well as trench shields and shoring products, catering to residential and non-residential construction, agriculture, and various infrastructure projects. The Engineered Structures segment supplies essential utility structures, wind towers, traffic and lighting structures, telecommunication structures, and storage tanks, playing a vital role in electricity transmission, wind power generation, and roadway projects. The Transportation Products segment provides inland barges and components such as fiberglass barge covers and winches, in addition to essential cast components for industrial and mining applications. Arcosa also manufactures axles and coupling devices vital for freight, tank, locomotive, and passenger rail transport. The company incurred an income tax expense of $36,300,000.00 indicating its tax obligations, while the gross profit stands at $515,200,000.00 highlighting the company's profitability from core operations. Additionally, the company incurred an interest expense of $70,900,000.00 reflecting its debt servicing obligations. The weighted average number of diluted shares outstanding is 48,800,000.00 reflecting potential dilution effects, and the company recorded a net income of $93,700,000.00 reflecting its profitability. The stock is reasonably priced at $95.73 appealing to a broad range of investors. However, it also has a low average trading volume of 226,646.00 indicating lower market activity. With a mid-range market capitalization of $5,503,832,706.00 the company is a steady performer in the infrastructure sector. Arcosa is a key player in the Industrial - Infrastructure Operations industry, contributing significantly to the overall market landscape. It belongs to the Industrials sector, driving innovation and growth, and its position enhances its relevance among investors seeking stability and potential returns.

What is Arcosa, Inc. (ACA)'s current stock price?

The current stock price of Arcosa, Inc. (ACA) is $111.22 as of 2025-12-19. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Arcosa, Inc. (ACA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Arcosa, Inc. stock to fluctuate between $68.11 (low) and $113.25 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-12-19, Arcosa, Inc.'s market cap is $5,503,832,706, based on 49,045,025 outstanding shares.

Compared to Meta Platforms, Inc. Class A Common Stock, Arcosa, Inc. has a Lower Market-Cap, indicating a difference in performance.

Arcosa, Inc. pays dividends. The current dividend yield is 0.18%, with a payout of $0.05 per share.

To buy Arcosa, Inc. (ACA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ACA. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Revenue: $2,569,900,000 | EPS: $1.92 | Growth: -41.28%.

Visit https://www.arcosa.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $113.43 (2024-11-25) | All-time low: $43.42 (2022-02-10).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

ACA

investors.com

S&P 500 Health Care Stocks Sink With Time Running Out On ACA Subsidies

A last-ditch effort by GOP moderates to renew the subsidies may be on life support.

ACA

businesswire.com

Arcosa, Inc. Declares Quarterly Dividend

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.05 per share on its $0.01 par value common stock. The quarterly cash dividend is payable on January 30, 2026 to stockholders of record as of January 15, 2026. About Arcosa Arcosa, Inc. (NYSE:ACA), headquartered in Dallas, Texas, is a provider of infrastructure-r.

ACA

seekingalpha.com

Oscar Health: Banking On The ACA Enrollment Expansion (Rating Upgrade)

Oscar Health is rerated as a bullish pick, driven by ACA enrollment expansion into Alabama, Southern Florida, and other high-growth regions. OSCR projects a 2027 market reach of 24 million members without subsidies and 31 million with subsidies, supporting robust revenue growth. Despite regulatory uncertainty around ACA subsidies expiring after 2025, OSCR's expansion, affordable plans, and innovative offerings position it well for membership growth.

ACA

fool.com

Forget CVS, Buy This Healthcare Stock Instead

Centene's stock is poised to gain if ACA subsidies are extended in December. The company's fortunes are closely tied to Medicare, Medicaid, and the ACA.

ACA

zacks.com

Is Arcosa (ACA) Stock Outpacing Its Construction Peers This Year?

Here is how Arcosa (ACA) and DIRTT Environmental Solutions Ltd. (DRTTF) have performed compared to their sector so far this year.

ACA

zacks.com

3 Reasons Why Growth Investors Shouldn't Overlook Arcosa (ACA)

Arcosa (ACA) possesses solid growth attributes, which could help it handily outperform the market.

ACA

zacks.com

ACA or IBP: Which Is the Better Value Stock Right Now?

Investors interested in Building Products - Miscellaneous stocks are likely familiar with Arcosa (ACA) and Installed Building Products (IBP). But which of these two stocks presents investors with the better value opportunity right now?

ACA

investopedia.com

Health Insurer Stocks Slide on President Trump's Call to Change ACA Payments

Centene (CNC), HCA Healthcare (HCA) and Molina Healthcare (MOH) are among the worst-performing stocks in the S&P 500 Monday after President Donald Trump suggested federal health care money should circumvent insurers and go directly to people.

ACA

zacks.com

Are Construction Stocks Lagging Arcosa (ACA) This Year?

Here is how Arcosa (ACA) and Babcock International Group PLC (BCKIY) have performed compared to their sector so far this year.

ACA

zacks.com

Arcosa (ACA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Arcosa (ACA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener